MARKET RADAR
SENSEX     NIFTY      Refresh
Moneycontrol.com India | Notes to Account > Pharmaceuticals > Notes to Account from Vivimed Labs - BSE: 532660, NSE: VIVIMEDLAB
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > NOTES TO ACCOUNTS - Vivimed Labs
Vivimed Labs
BSE: 532660|NSE: VIVIMEDLAB|ISIN: INE526G01013|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 23, 17:00
293.10
-3.3 (-1.11%)
VOLUME 7,950
LIVE
NSE
May 23, 17:00
292.15
-4.05 (-1.37%)
VOLUME 8,236
« Mar 11
Notes to Accounts Year End : Mar '12
1.  Preference Share Capital:
 
 During the Financial Year 2011-12, the company allotted 6,70,000
 Compulsory Convertible Cumulative Preference shares of Rs.  1,000/-
 each to M/s. Nylim Jacob Ballas India Fund III, LLC at par.
 
 2.  Warrant Application Money of Rs. 23.72 mn received during the
 earlier years represents monies received for which Warrants were not
 issued by the company for want of approval from Stock Exchanges.
 
 3.  Long Term Borrowings:
 
 (a) Term Loans From Banks:
 
 1) EXIM Bank: Closing Balance as on 31-03-2012 - Rs. 345.07 mn.
 
 Secured by Pari passu First charge on the Immovable and Movable Assets
 of the Company present and future including Equitable Mortgage of
 Factory Lands and Buildings and Second pari passu charge on the Current
 Assets.
 
 2) State Bank of Hyderabad: Closing Balance as on 31-03-2012 - Rs.
 100.24 mn.
 
 Short Term Corporate Loan - Secured by Pari Passu First Charge on the
 Immovable and Movable Assets of the Company present and future
 including equitable mortgage of Factory Lands and Buildings and Second
 Pari Passu charge on Current Assets.
 
 3) Axis Bank: Closing Balance as on 31-03-2012 - Rs. 308.66 mn.
 
 Secured by Pari Passu First Charge on the Immovable and Movable Assets
 of the Company present and future including equitable mortgage of
 Factory Lands and Buildings and Second Pari Passu charge on Current
 Assets.
 
 4) Term Loans against Hypothecation of Vehicles:
 
 Closing Balance as on 31-03-2012 - Rs. 2.01 mn. Secured by
 Hypothecation of specific Vehicles of the Company.
 
 5) Mortgage Loan from HDFC Bank :
 
 Closing Balance as on 31-03-2012 - Rs. 1.09 mn. Secured by Mortgage of
 specific Immovable Property.
 
 (b) Unsecured Loans from Banks:
 
 Kotak Mahindra Bank : Closing Balance as on 31-03-2012 - Rs.200.00 mn.
 
 (c) Unsecured Loan from Financial Institution:
 
 International Finance Corporation Closing Balance as on 31-03-2012 -
 Rs.333.50 mn.
 
 75 Nos. Optionally Convertible / Redeemable Foreign Currency Bonds
 (F.C.C.B.) at the face value of USD 100,000 each.
 
 4.  Treatment of Capital Work in Progress :
 
 Capital Work in Progress includes Cost of Land under acquisition and
 Plant, Machinery & Equipments under installation.
 
 5.  Detailed information regarding quantitative particulars under part
 II of schedule VI to the Companies Act, 1956 :
 
 i) Quantitative information with regard to
 
 a) Licensed Capacity and Installed Capacity per annum
 
 6. Contingent Liabilities :                         (Rs. in Rs.)
 
                                                 As at         As at
 Particulars                                31.03.2012      31.03.2011
 
 Letter of Credit Foreign LC''s                 94.69           151.93
 
 Inland LC''s                                   55.89            32.48
 
 SBLC – Axis Bank                              51.15              -
 
 Bank Guarantee State Bank of Hyderabad, 
 Balanagar Branch, Hyderabad.                   4.87             4.87
 
 7. Amount of delayed outstanding dues to Micro and Small Enterprise as
 per MSME Development Act, 2006, could not be ascertained at the end of
 the Financial Year.
 
 8.  Segment wise Information is furnished in Annexure -A.
 
 9.  Closing Balances of Debtors / Creditors / Loans & Advances are
 subjected to confirmation from the parties.
 
 10.  Previous year''s numbers have been regrouped, rearranged, recasted,
 wherever necessary to conform to Current Year Classification.
 
 11.  The numbers have been rounded off to the nearest millions of
 rupees.
 
 Segment Information:
 
 Company has identified two reporting segments viz., Speciality
 Chemicals and Pharmaceuticals. Segments have been identified and
 reported taking into account nature of products and services the
 differing risks, returns and the internal business reporting systems.
 Accounting policies adopted for segment reporting are in line with
 Accounting Policy of the company and are in accordance with the AS-17.
Source : Dion Global Solutions Limited
Quick Links for vivimedlabs
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.